ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $207,000 | – | 4,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 530,670 | $49,320,000 | 10.96% |
| Paradigm Biocapital Advisors LP | 251,777 | $23,400,000 | 6.68% |
| RAMIUS ADVISORS LLC | 161,770 | $15,035,000 | 5.27% |
| First Light Asset Management, LLC | 645,848 | $60,025,000 | 4.30% |
| Affinity Asset Advisors, LLC | 100,000 | $9,294,000 | 3.38% |
| SECTORAL ASSET MANAGEMENT INC | 230,043 | $21,380,000 | 3.22% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 806,200 | $74,929,000 | 2.80% |
| DAFNA Capital Management LLC | 119,615 | $11,117,000 | 2.80% |
| HAVENS ADVISORS LLC | 24,500 | $2,277,000 | 2.69% |
| Prosight Management, LP | 45,000 | $4,182,000 | 2.50% |